| scholarly article | Q13442814 |
| P356 | DOI | 10.1084/JEM.179.2.651 |
| P8608 | Fatcat ID | release_wo43udw53jhulhgalbeyrqv2zy |
| P932 | PMC publication ID | 2191384 |
| P698 | PubMed publication ID | 7507509 |
| P5875 | ResearchGate publication ID | 277501821 |
| P50 | author | Gary S. Gilkeson | Q67485105 |
| Michael F Seldin | Q107119154 | ||
| P2093 | author name string | E R Wood | |
| P Ruiz | |||
| D S Pisetsky | |||
| J B Weinberg | |||
| A M Pippen | |||
| D L Granger | |||
| S N Mason | |||
| M A Misukonis | |||
| P2860 | cites work | Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17q | Q24613068 |
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| Linkage of early-onset familial breast cancer to chromosome 17q21 | Q28268902 | ||
| Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg | Q28269092 | ||
| Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide | Q29547245 | ||
| Nitric oxide as a secretory product of mammalian cells | Q29620372 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| Localization of brain nitric oxide synthase (NOS) to human chromosome 12. | Q31172295 | ||
| Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases | Q33584105 | ||
| Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum | Q34320881 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Type 1 (insulin-dependent) diabetes mellitus and nitric oxide | Q35349553 | ||
| The non-obese diabetic (NOD) mouse | Q35856058 | ||
| Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci | Q36232118 | ||
| Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains | Q36342054 | ||
| Genetic analysis of autoimmune gld mice. I. Identification of a restriction fragment length polymorphism closely linked to the gld mutation within a conserved linkage group | Q36354433 | ||
| Suppression of arthritis by an inhibitor of nitric oxide synthase | Q36362115 | ||
| Role of nitric oxide synthesis in macrophage antimicrobial activity | Q36656920 | ||
| Tissue injury caused by deposition of immune complexes is L-arginine dependent | Q37552653 | ||
| Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line | Q38329889 | ||
| Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53. | Q40461080 | ||
| Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line | Q41514909 | ||
| Hepatocytes and Macrophages Express an Identical Cytokine-Inducible Nitric Oxide Synthase Gene | Q41565085 | ||
| Nitric oxide modulation of human leukemia cell differentiation and gene expression | Q41598756 | ||
| Clustering of cytokine genes on mouse chromosome 11. | Q41739605 | ||
| Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/lty/Bcg genes on chromosome 1 | Q42620654 | ||
| In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse | Q43939897 | ||
| Genetic analysis of autoimmune type 1 diabetes mellitus in mice | Q44110103 | ||
| Phorbol diester-induced H2O2 production by peritoneal macrophages. Different H2O2 production by macrophages from normal and BCG-infected mice despite comparable phorbol diester receptors | Q44327554 | ||
| Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis | Q44487593 | ||
| Urinary nitrate excretion in relation to murine macrophage activation. Influence of dietary L-arginine and oral NG-monomethyl-L-arginine. | Q44877296 | ||
| A linkage map of mouse chromosome 1 using an interspecific cross segregating for the gld autoimmunity mutation | Q45341202 | ||
| Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus | Q45800564 | ||
| Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice | Q57782997 | ||
| Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis | Q59851915 | ||
| Genomic organization of adrenergic and serotonin receptors in the mouse: Linkage mapping of sequence-related genes provides a method for examining mammalian chromosome evolution | Q62394171 | ||
| Peroxynitrite formation from macrophage-derived nitric oxide | Q67505344 | ||
| Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice | Q67519429 | ||
| Bactericidal activity of peroxynitrite | Q67568060 | ||
| Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginine | Q67896420 | ||
| Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'-diphosphate and bradykinin | Q68046905 | ||
| A molecular genetic linkage map of mouse chromosome 7 | Q68166997 | ||
| Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide | Q68261503 | ||
| Enhanced interferon-gamma (IFN) production by lymph node cells from autoimmune (MRL/1, MRL/n) mice | Q69219451 | ||
| Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA | Q69485992 | ||
| Genetic control of inflammatory arthritis in congenic lpr mice | Q69778770 | ||
| Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice | Q70328428 | ||
| Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds | Q70560366 | ||
| Spontaneous T-cell lymphokine production and enhanced macrophage Ia expression and tumoricidal activity in MRL-lpr mice | Q71480939 | ||
| Induction of Nitric Oxide Synthase in Human Chondrocytes | Q72082340 | ||
| The information content of phase-known matings for ordering genetic loci | Q93671908 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathogenesis | Q372016 |
| glomerulonephritis | Q605006 | ||
| autoimmune disease | Q8084905 | ||
| P304 | page(s) | 651-660 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orall | |
| P478 | volume | 179 |
| Q24755844 | 2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo |
| Q47840679 | Aberrant Timing in Epidermal Expression of Inducible Nitric Oxide Synthase After UV Irradiation in Cutaneous Lupus Erythematosus |
| Q41723099 | Activation and potential interactions between the arachidonic acid and L-arginine:nitric oxide pathways in glomerulonephritis |
| Q34000575 | Activation of murine macrophages by lipoprotein and lipooligosaccharide of Treponema denticola |
| Q33767460 | Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection. |
| Q47746594 | Activation of purinergic P2Y2 receptors inhibits inducible NO synthase in cultured rat mesangial cells |
| Q74317626 | Age-related alterations in inflammatory response during experimental autoimmune prostatitis |
| Q46388109 | Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors |
| Q47100704 | Air pollution, oxidative stress, and exacerbation of autoimmune diseases |
| Q50868971 | Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-β1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice |
| Q34212538 | Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells |
| Q38528298 | An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats |
| Q34367944 | An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality |
| Q30470432 | Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes |
| Q41469780 | Angiotensin II and L-arginine in tissue fibrosis: more than blood pressure. |
| Q41678178 | Antiinflammatory effects of NADPH oxidase inhibitors. |
| Q36300619 | Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model |
| Q84897845 | Assessment of Mitochondrial Dysfunction in Lymphocytes of Patients with Systemic Lupus Erythematosus |
| Q37323378 | Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis |
| Q40343340 | Autocrine inhibition of Na+/K(+)-ATPase by nitric oxide in mouse proximal tubule epithelial cells |
| Q41850306 | Biochemistry of nitric oxide |
| Q34001952 | Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria |
| Q33868735 | C5a alters blood-brain barrier integrity in experimental lupus |
| Q36437834 | Characterization and functional analysis of the human inducible nitric oxide synthase gene promoter. |
| Q40460160 | Characterization of Signals Leading to Clonal Expansion or to Cell Death During Lymphocyte B Cell Activation |
| Q34108825 | Circulating endothelial cells and vascular injury in systemic lupus erythematosus |
| Q36380452 | Clinical and Serologic Manifestations of Autoimmune Disease in MRL-lpr/lpr Mice Lacking Nitric Oxide Synthase Type 2 |
| Q41044778 | Cyclic Adenosine Monophosphate Inhibits Nitric Oxide-Induced Apoptosis in Human Leukemic HL-60 Cells |
| Q38334223 | Cytokine-mediated Transcriptional Induction of the Human Inducible Nitric Oxide Synthase Gene Requires Both Activator Protein 1 and Nuclear Factor κB-binding Sites |
| Q42476776 | Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney |
| Q28360546 | Diphenyleneiodonium inhibits NF-kappaB activation and iNOS expression induced by IL-1beta: involvement of reactive oxygen species |
| Q38828358 | Effect of N-Feruloylserotonin and Methotrexate on Severity of Experimental Arthritis and on Messenger RNA Expression of Key Proinflammatory Markers in Liver |
| Q36061633 | Effect of late modulation of nitric oxide production on murine lupus |
| Q44114226 | Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice |
| Q46066180 | Effector and predisposing genes in murine lupus |
| Q39594689 | Effects of Luteolin on the Release of Nitric Oxide and Interleukin‐6 by Macrophages Stimulated With Lipopolysaccharide From Prevotella Intermedia |
| Q42441946 | Effects of Oral Administration of Malathion on the Course of Disease in MRL-lpr Mice |
| Q40650841 | Effects of high glucose on NO synthesis in human keratinocyte cell line (HaCaT) |
| Q41433634 | Effects of the cytokine synthesis inhibitor CGP 47969A on nitric oxide production by lipopolysaccharide-stimulated J774A.1 macrophages |
| Q36445412 | Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells |
| Q42527141 | Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. |
| Q33715480 | Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. |
| Q36434533 | Endothelial nitric oxide synthase inhibits the development of autoimmune‐mediated vasculitis in mice |
| Q35555916 | Endothelial nitric oxide synthase: a determinant of TNFα production by human monocytes/macrophages |
| Q88034813 | Environmental Agents, Oxidative Stress and Autoimmunity |
| Q71358014 | Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats |
| Q42721201 | Evidence suggesting a nitric oxide-scavenging activity for traditional crude drugs, and action mechanisms of Sanguisorbae Radix against oxidative stress and aging |
| Q47752650 | Exhaled nitric oxide, pulmonary function, and disease activity in children with systemic lupus erythematosus. |
| Q35798607 | Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis |
| Q71549292 | Failure of L-NAME to cause inhibition of nitric oxide synthesis: role of inducible nitric oxide synthase |
| Q40399256 | From apoptosis to autoimmunity: insights from the signaling pathways leading to proliferation or to programmed cell death. |
| Q73740093 | Gender-dependent effect of L-NAME on polycystic kidney disease in Han:SPRD rats |
| Q57186323 | Genetic mapping of the ?-arrestin 1 and 2 genes on mouse Chromosomes 7 and 11 respectively |
| Q33893349 | Genetics of systemic lupus erythematosus. Clinical implications |
| Q71754545 | Glomerular actions of nitric oxide |
| Q54561304 | Glomerular and vascular tissues do not down-regulate nitric oxide synthesis during protracted endotoxemia |
| Q37143338 | Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis |
| Q34837305 | Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. |
| Q34009831 | Host Response to Infection: the Role of CpG DNA in Induction of Cyclooxygenase 2 and Nitric Oxide Synthase 2 in Murine Macrophages |
| Q24540361 | Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: The role of NF-kappa B-repressing factor (NRF) in basal repression of the hiNOS gene |
| Q35996121 | Immune Complex-Induced, Nitric Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented with Decoy FcγReceptors |
| Q71804111 | In vivo pharmacological evaluation off two novel type II (inducible) nitric oxide synthase inhibitors |
| Q37355240 | In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. |
| Q47718591 | Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-l-lysine and N5-iminoethyl-l-ornithine |
| Q36367259 | Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients |
| Q44325051 | Increased inducible nitric oxide synthase expression and nitric oxide concentration in patients with aplastic anemia |
| Q33722895 | Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus |
| Q37324796 | Increased nitration and carbonylation of proteins in MRL+/+ mice exposed to trichloroethene: potential role of protein oxidation in autoimmunity |
| Q51094364 | Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC) |
| Q40964556 | Increased oxidative stress in the RAW 264.7 macrophage cell line is partially mediated via the S-nitrosothiol-induced inhibition of glutathione reductase |
| Q36181128 | Inducible nitric oxide synthase and inflammation |
| Q89745949 | Inducible nitric oxide synthase and systemic lupus erythematosus: a systematic review and meta-analysis |
| Q37380089 | Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. |
| Q27480810 | Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection |
| Q37088054 | Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene |
| Q40371583 | Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis |
| Q54983845 | Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection |
| Q36973647 | Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling |
| Q41214629 | Induction of cyclo-oxygenase and nitric oxide synthase in inflammation |
| Q37856590 | Induction of iNOS by Chlamydophila pneumoniae requires MyD88-dependent activation of JNK. |
| Q73567954 | Influence of Photofrin® on the Hematopoietic Accessory Function of Murine Peritoneal Cells |
| Q35653669 | Inhibition of NOS-NO System Prevents Autoimmune Orchitis Development in Rats: Relevance of NO Released by Testicular Macrophages in Germ Cell Apoptosis and Testosterone Secretion |
| Q41208757 | Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties |
| Q73388582 | Inhibition of macrophage nitric oxide production by tetrahydrocannabinol in vivo and in vitro |
| Q37377479 | Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice |
| Q42840040 | Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice |
| Q41888302 | Interrelationship of the kinin system, nitric oxide and eicosanoids in the antigen-induced arthritis in rabbits |
| Q74579517 | Involvement of Nitric Oxide Synthase in Proteinuria Associated with Chronic Renal Disease in Rats |
| Q39318615 | Kaempferol inhibits P. intermedia lipopolysaccharide-induced production of nitric oxide through translational regulation in murine macrophages: critical role of heme oxygenase-1-mediated ROS reduction. |
| Q34344023 | L-arginine may mediate the therapeutic effects of low protein diets |
| Q71865048 | L-arginine metabolism in immune-mediated glomerulonephritis in the rat |
| Q71650774 | L-thiocitrulline. A stereospecific, heme-binding inhibitor of nitric-oxide synthases |
| Q70911066 | Lack of inducible nitric oxide synthase activity in T cell clones and T lymphocytes from naive and Leishmania major-infected mice |
| Q40121887 | Lipid A-associated proteins from Porphyromonas gingivalis stimulate release of nitric oxide by inducing expression of inducible nitric oxide synthase |
| Q35688862 | Lipopolysaccharide induces inducible nitric oxide synthase-dependent podocyte dysfunction via a hypoxia-inducible factor 1α and cell division control protein 42 and Ras-related C3 botulinum toxin substrate 1 pathway |
| Q37378097 | Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice |
| Q22242390 | Lyme borreliosis: from infection to autoimmunity |
| Q35551240 | Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis |
| Q35503952 | Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters |
| Q34111316 | Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity |
| Q28383739 | Mechanisms of tissue injury in lupus nephritis |
| Q39620081 | Melatonin inhibits Prevotella intermedia lipopolysaccharide‐induced production of nitric oxide and interleukin‐6 in murine macrophages by suppressing NF‐κB and STAT1 activity |
| Q37187126 | Metabolic control of T cell activation and death in SLE. |
| Q73904476 | Methotrexate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis |
| Q25255941 | Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology |
| Q34005722 | Modulation of autoimmune diseases by nitric oxide |
| Q36366341 | Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. |
| Q41692683 | Multiple controls in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase |
| Q40697333 | Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages |
| Q37341275 | NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis |
| Q41307762 | NF-kappa B and transcriptional control of renal epithelial-inducible nitric oxide synthase |
| Q35829420 | NOS-2 mediates the protective anti-inflammatory and antifibrotic effects of the Th1-inducing adjuvant, IL-12, in a Th2 model of granulomatous disease |
| Q43804920 | Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice |
| Q41090104 | Nitric Oxide Inhibits Fas-induced Apoptosis |
| Q70928358 | Nitric oxide |
| Q41658991 | Nitric oxide and inflammatory arthritides |
| Q64443244 | Nitric oxide and inflammatory disorders of the skin |
| Q24645400 | Nitric oxide and peroxynitrite in health and disease |
| Q36891974 | Nitric oxide and vascular remodeling: spotlight on the kidney |
| Q42031614 | Nitric oxide as a mediator of inflammation?-You had better believe it. |
| Q34941147 | Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice |
| Q73205004 | Nitric oxide augments release of chemokines from monocytic U937 cells: modulation by anti-inflammatory pathways |
| Q77723681 | Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? |
| Q40405166 | Nitric oxide in hypertension and renal diseases |
| Q40405174 | Nitric oxide in inflammation and immune response |
| Q41591110 | Nitric oxide in renal health and disease |
| Q73347815 | Nitric oxide increased interleukin-4 expression in T lymphocytes |
| Q41837758 | Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage |
| Q35766373 | Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides |
| Q35442506 | Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. |
| Q37255930 | Nitric oxide production in SJL mice bearing the RcsX lymphoma: a model for in vivo toxicological evaluation of NO |
| Q35556126 | Nitric oxide regulates clonal expansion and activation-induced cell death triggered by staphylococcal enterotoxin B |
| Q35753247 | Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha |
| Q34242689 | Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation |
| Q45757124 | Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. |
| Q74319609 | Nitric oxide, L-arginine and the kidney. Experimental studies of new therapy approaches |
| Q40399921 | Nitric oxide. Novel biology with clinical relevance |
| Q31162430 | Nitrosative stress and nitrated proteins in trichloroethene-mediated autoimmunity |
| Q74069414 | Nitrosylation of Blood Hemoglobin and Renal Nonheme Proteins in Autoimmune MRL-lpr/lpr Mice |
| Q37635827 | Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells |
| Q34535919 | Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway |
| Q28384392 | Oxidant Mechanisms in Renal Injury and Disease |
| Q37375753 | Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells |
| Q77357142 | Potentiation of nitric oxide synthase expression by superoxide in interleukin 1β‐stimulated rat mesangial cells |
| Q73195049 | Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin |
| Q42943792 | Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients |
| Q30300218 | Reduced Renal Methylarginine Metabolism Protects against Progressive Kidney Damage |
| Q74460378 | Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation |
| Q41133709 | Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. |
| Q44361092 | Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage. Role of endogenous IL-1 inhibitors |
| Q35909718 | Role of L-arginine in the pathogenesis and treatment of renal disease |
| Q73714791 | Role of Salviae Miltiorrhizae Radix extract and its compounds in enhancing nitric oxide expression |
| Q44349843 | Role of central mu-opioid receptors in the modulation of nitric oxide production by splenocytes |
| Q36363736 | Role of interferon regulatory factor 1 in induction of nitric oxide synthase |
| Q48012472 | Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus |
| Q74819865 | Role of poly(ADP-ribose)synthetase in inflammation |
| Q77418661 | Role of tumour necrosis factor-α and inducible nitric oxide synthase in the prevention of nitro-flurbiprofen small intestine toxicity |
| Q34247796 | S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis |
| Q40473381 | Self and non-self antigen in diabetic autoimmunity: Molecules and mechanisms |
| Q35550935 | Serum nitrate and nitrite levels in patients with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis |
| Q35605666 | Serum, urinary, and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures |
| Q36366625 | Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse |
| Q33608479 | Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment. |
| Q33718893 | T-cell and B-cell signaling biomarkers and treatment targets in lupus |
| Q71673360 | Tetrahydrobiopterin is a limiting factor of nitric oxide generation in interleukin 1 beta-stimulated rat glomerular mesangial cells |
| Q35603929 | The DDAH/ADMA/NOS pathway |
| Q42971599 | The Multiplex Function of Nitric Oxide in (Auto)immunity |
| Q74576259 | The Therapeutic Potential of Nitric Oxide in Lung Transplantation |
| Q50097239 | The anti-inflammatory effect of Agaricus brasiliensis is partly due to its linoleic acid content |
| Q39269497 | The anti-inflammatory effects of ethyl acetate on Lipopolysaccharide/D-galactosamine challenged mice and Lipopolysaccharide activated RAW264.7 cells |
| Q44188838 | The antithyroid agent 6-n-propyl-2-thiouracil is a mechanism-based inactivator of the neuronal nitric oxide synthase isoform |
| Q36544017 | The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus |
| Q33802441 | The biology of reactive intermediates in systemic lupus erythematosus |
| Q74414367 | The effects of static and intermittent compression on nitric oxide production in articular cartilage explants |
| Q34373452 | The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs). |
| Q98467033 | The protective effect and mechanism of lentinan on acute kidney injury in septic rats |
| Q77363180 | The relationship between endothelins and eicosanoids in the vasculature |
| Q36366549 | The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice |
| Q35124943 | The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus |
| Q47849314 | The role of nitric oxide in inflammation and immunity |
| Q36939711 | The role of nitric oxide in osteoarthritis |
| Q38524837 | The water extract of Samultang protects the lipopolysaccharide (LPS)/phorbol 12-myristate 13-acetate (PMA)-induced damage and nitric oxide production of C6 glial cells via down-regulation of NF-kappaB. |
| Q44217209 | Thymoquinone suppresses expression of inducible nitric oxide synthase in rat macrophages |
| Q36363951 | Transforming growth factor beta: the good, the bad, and the ugly |
| Q40622903 | Treponemal glycoconjugate inhibits Toll‐like receptor ligand‐induced cell activation by blocking LPS‐binding protein and CD14 functions |
| Q33782338 | Tumour necrosis factor and other cytokines in murine lupus |
| Q38777852 | Understanding mechanisms of hypertension in systemic lupus erythematosus |
| Q54587987 | Upregulation of group IB secreted phospholipase A(2) and its M-type receptor in rat ANTI-THY-1 glomerulonephritis |
| Q73406196 | Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis |
| Q34630285 | Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice |
| Q36386284 | iNOS null MRL+/+ mice show attenuation of trichloroethene-mediated autoimmunity: contribution of reactive nitrogen species and lipid-derived reactive aldehydes |
Search more.